Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

A selective Liver X Receptor inverse agonist lowered triglycerides and post-meal cholesterol in people, opening a safer path ...

Researchers developed TLC-2716, a liver- and gut-targeted drug that selectively reduced LXR activity, lowering triglycerides, ...

In A Nutshell The small, short trial showed no serious side effects, but much larger and longer studies are needed to prove ...

Not all proteins function the same way in the body, especially when it comes to heart health. In a review of controlled ...

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Resistant starch is a nondigestible fiber that ferments in the large intestine, and consumption of it has previously been shown to have a positive effect on metabolism in animal studies. Now, a ...

November 9, 2010 (Boston, Massachusetts) — A 4.3% reduction in body weight and an approximate 42% reduction of triglyceride levels in subjects with nonalcoholic fatty liver disease (NAFLD) was ...

New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.